PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
20-May-2025 Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease Tiziana
20-May-2025 New Phesi analysis of 167 million patient records finds colorectal cancer has largest volume of real-world data, but oncology trials still lack modernization Phesi
20-May-2025 New Phesi analysis of 167 million patient records finds colorectal cancer has largest volume of real-world data, but oncology trials still lack modernization Phesi
20-May-2025 Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis Philikos
20-May-2025 Henkel and Nordmeccanica elevate long-standing cooperation into a strategic partnership Henkel and Nordmeccanica
20-May-2025 Veranova Appoints Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence Veranova
20-May-2025 TIACA Announces Roos Bakker to be the Next TIACA Chair, Taking Over from Steven Polmans When His Term Finishes at the End of 2025. TIACA
20-May-2025 Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim Brainomix
20-May-2025 UK Blood Test That Detects Lung Cancer Early Secures New Funding for UK Rollout Cizzle Biotechnology
20-May-2025 Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference Zymeworks
20-May-2025 Xinnate Announces Successful FDA Meeting for TCP-25 Xinnate
20-May-2025 CellProthera Selects CELLforCURE by SEQENS for Phase 3 GMP Manufacturing  CellProthera
20-May-2025 Kanceraprovides an update on the collaboration with Recardio Inc. and the company’s clinical development program Kancera
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock AdrenoMed AG
14-May-2025 High-Dose Radiotherapy: Safe and Promising for Lung Cancer KL Krems
14-May-2025 Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025 Akero Therapeutics
14-May-2025 Aqilion receives IND approval from FDA Aqilion
14-May-2025 Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT Axovia Therapeutics
14-May-2025 eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture eXmoor Pharma
14-May-2025 iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients iTeos